Norvinisterone

Norvinisterone
Clinical data
Trade names	Neoprogestin, Nor-Progestelea
Other names	Vinylnortestosterone; SC-4641; 17α-Vinyl-19-nortestosterone; 17α-Vinylestr-4-en-17β-ol-3-one
Routes of; administration	By mouth
Drug class	Progestogen; Progestin; Androgen; Anabolic steroid
ATC code	None;
Identifiers
	IUPAC name (8R,9S,10R,13S,14S,17R)-17-ethenyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;
CAS Number	6795-60-4;
PubChem CID	65588;
ChemSpider	59030;
UNII	7Q843V12Q0;
Chemical and physical data
Formula	C20H28O2
Molar mass	300.442 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	169 to 171 °C (336 to 340 °F)
	SMILES O=C4\C=C2/[C@@H]([C@H]1CC[C@@]3([C@](O)(\C=C)CC[C@H]3[C@@H]1CC2)C)CC4;
	InChI InChI=1S/C20H28O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h3,12,15-18,22H,1,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1; Key:VOJYZDFYEHKHAP-XGXHKTLJSA-N;

Norvinisterone, sold under the brand names Neoprogestin and Nor-Progestelea, is a progestin and androgen/anabolic steroid (AAS) medication which was used in Europe but is now no longer marketed.^[1]^[2]^[3]^[4]^[5] It is taken by mouth.

Norvinisterone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone.^[2] It has androgenic activity.^[6]

Norvinisterone was synthesized in 1953.^[2] It is no longer available.^[7]

Medical uses[]

Norvinisterone was used in hormonal contraception to prevent pregnancy.^[1]^[3]

Pharmacology[]

Pharmacodynamics[]

Norvinisterone is a progestogen.^[2]^[8]^[5] It appears to be quite androgenic, with about one-third and one-fifth of the androgenic and anabolic activity, respectively, of nandrolone in animal bioassays.^[6] However, it has also been reported to have little anabolic activity.^[9]

Chemistry[]

Norvinisterone, also known as 17α-vinyl-19-nortestosterone or as 17α-vinylestr-4-en-17β-ol-3-one, is a synthetic estrane steroid and a derivative of testosterone and 19-nortestosterone.^[2] Analogues of norvinisterone include the progestin norgesterone and the AAS vinyltestosterone.^[2]

History[]

Norvinisterone was synthesized in 1953^[2] and was studied in humans by 1960.^[8]

Society and culture[]

Generic names[]

Norvinisterone is the generic name of the drug and its INN.^[2] It is also known as vinylnortestosterone and is known by its developmental code name SC-4641.^[2]^[1]

Brand names[]

Norvinisterone was marketed under the brand names Neoprogestin and Nor-Progestelea by Syntex.^[2]^[1]

Availability[]

Norgesterone is no longer marketed and hence is no longer available in any country.^[7]

References[]

^ ^a ^b ^c ^d ^e Merck Index, 11th edition, 6637
^ ^a ^b ^c ^d ^e ^f ^g ^h ⁱ ^j J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 889–. ISBN 978-1-4757-2085-3.
^ ^a ^b Pei-Show Juo (21 December 2001). Concise Dictionary of Biomedicine and Molecular Biology. CRC Press. pp. 774–. ISBN 978-1-4200-4130-9.
^ P. H. List; L. Hörhammer (12 March 2013). Chemikalien und Drogen Teil A: N-Q. Springer Berlin Heidelberg. pp. 274–. ISBN 978-3-642-65035-2.
^ ^a ^b Meyerson, Bengt J. (1967). "Relationship Between the Anesthetic and Gestagenic Action and Estrous Behavior-Inducing Activity of Different Progestins". Endocrinology. 81 (2): 369–374. doi:10.1210/endo-81-2-369. ISSN 0013-7227. PMID 4952012.
^ ^a ^b Saunders, Francis J.; Drill, Victor A. (1956). "The Myotrophic and Androgenic Effects of 17-Ethyl-19-nortestosterone and Related Compounds". Endocrinology. 58 (5): 567–572. doi:10.1210/endo-58-5-567. ISSN 0013-7227. PMID 13317831.
^ ^a ^b http://www.micromedexsolutions.com/micromedex2/^{[permanent dead link]}
^ ^a ^b Martinez Montes EA, Bagnati EP, Zapata AC, Bur GE (1960). "[Clinical trial of a new luteoid: norvinisterone]". Dia Med (in Spanish). 32: 194–7. PMID 14421807.
^ SCHEDL HP, DELEA C, BARTTER FC (August 1959). "Structure-activity relationships of anabolic steroids: role of the 19-methyl group". J. Clin. Endocrinol. Metab. 19 (8): 921–35. doi:10.1210/jcem-19-8-921. PMID 14442516.

[Merck-1] Merck Index, 11th edition, 6637

[Elks2014-2] ^ ^a ^b ^c ^d ^e ^f ^g ^h ⁱ ^j J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 889–. ISBN 978-1-4757-2085-3.

[Juo2001-3] Pei-Show Juo (21 December 2001). Concise Dictionary of Biomedicine and Molecular Biology. CRC Press. pp. 774–. ISBN 978-1-4200-4130-9.

[ListHörhammer2013-4] P. H. List; L. Hörhammer (12 March 2013). Chemikalien und Drogen Teil A: N-Q. Springer Berlin Heidelberg. pp. 274–. ISBN 978-3-642-65035-2.

[Meyerson1967-5] Meyerson, Bengt J. (1967). "Relationship Between the Anesthetic and Gestagenic Action and Estrous Behavior-Inducing Activity of Different Progestins". Endocrinology. 81 (2): 369–374. doi:10.1210/endo-81-2-369. ISSN 0013-7227. PMID 4952012.

[SaundersDrill1956-6] Saunders, Francis J.; Drill, Victor A. (1956). "The Myotrophic and Androgenic Effects of 17-Ethyl-19-nortestosterone and Related Compounds". Endocrinology. 58 (5): 567–572. doi:10.1210/endo-58-5-567. ISSN 0013-7227. PMID 13317831.

[Micromedex-7] ttp://www.micromedexsolutions.com/micromedex2/^{[permanent dead link]}

[pmid14421807-8] Martinez Montes EA, Bagnati EP, Zapata AC, Bur GE (1960). "[Clinical trial of a new luteoid: norvinisterone]". Dia Med (in Spanish). 32: 194–7. PMID 14421807.

[pmid14442516-9] SCHEDL HP, DELEA C, BARTTER FC (August 1959). "Structure-activity relationships of anabolic steroids: role of the 19-methyl group". J. Clin. Endocrinol. Metab. 19 (8): 921–35. doi:10.1210/jcem-19-8-921. PMID 14442516.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]